MDGL
Madrigal Pharmaceuticals Inc
531.50$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Investor relations
Report Dates
Investor relations overview for Madrigal Pharmaceuticals Inc (MDGL): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.
Next report
11/03/2026
Last report
07/30/2026
EPS estimate beaten
Full history
39 of 77 quarters (51%)
Last 16 quarters
8 of 16 quarters (50%)
Earnings Call Transcripts
- 05/06/2026 Earnings Call Q1 2026 Open →
- 02/19/2026 Earnings Call Q4 2025 Open →
- 11/04/2025 Earnings Call Q3 2025 Open →
- 08/05/2025 Earnings Call Q2 2025 Open →
- 05/01/2025 Earnings Call Q1 2025 Open →
- 02/26/2025 Earnings Call Q4 2024 Open →
- 10/31/2024 Earnings Call Q3 2024 Open →
- 08/07/2024 Earnings Call Q2 2024 Open →
- 05/07/2024 Earnings Call Q1 2024 Open →
News on This Stock
- 08/12/2026 MADRIGAL PHARMACEUTICALS, INC. (MDGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 07/30/2026 MADRIGAL PHARMACEUTICALS, INC. (MDGL): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.